Emergex Vaccines

Description: Emergex develops T-cell vaccines using nanoclusters to prevent diseases like Zika & Ebola, mimicking natural infection without antibody side effects.

Country: UK

Based in: Abingdon

Founded: 2016

Funding Stage: Series A/B

Tags: ['BioTech', 'eHealth', 'Healthcare', 'Vaccination', 'Emergex Vaccines', 'Abingdon']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.